Financial reports
20-F
2023 FY
Annual report (foreign)
21 Feb 24
40-F
2022 FY
Annual report (Canada)
28 Feb 23
40-F
2021 FY
Annual report (Canada)
24 Feb 22
40-F
2020 FY
Annual report (Canada)
25 Feb 21
40-F
2019 FY
Annual report (Canada)
25 Feb 20
20-F/A
2013 FY
Annual report (foreign) (amended)
7 Apr 14
20-F
2013 FY
Annual report (foreign)
27 Feb 14
20-F
2012 FY
Annual report (foreign)
27 Feb 13
40-F/A
2011 FY
Annual report (Canada) (amended)
1 Feb 13
40-F/A
2011 FY
Annual report (Canada) (amended)
28 Feb 12
Current reports
6-K
Report on Voting Results
10 May 24
6-K
Theratechnologies Reports on its Annual Meeting of Shareholders
9 May 24
6-K
Notice of Annual Meeting of Shareholders
15 Apr 24
6-K
Interim Consolidated Financial Statements
10 Apr 24
6-K
Theratechnologies Reports Financial Results
10 Apr 24
6-K
Theratechnologies Appoints Elina Tea to its Board of Directors
5 Apr 24
6-K
Theratechnologies Announces Update on its Preclinical Oncology Research Program
22 Mar 24
6-K
Theratechnologies Appoints Jordan Zwick to its Board of Directors
22 Mar 24
6-K
Current report (foreign)
21 Mar 24
6-K
Theratechnologies Announces the Resignation of One of Its
29 Feb 24
Registration and prospectus
F-3/A
Shelf registration (foreign) (amended)
2 Jan 24
F-3
Shelf registration (foreign)
21 Dec 23
SUPPL
Supplemental materials (foreign)
26 Oct 23
SUPPL
Supplemental materials (foreign)
25 Oct 23
F-X
Appointment of agent for service of process by issuers registering securities
25 Oct 23
SUPPL
Supplemental materials (foreign)
17 Dec 21
F-10/A
Registration of securities (Canada) (amended)
15 Dec 21
F-10
Registration of securities (Canada)
23 Nov 21
SUPPL
Supplemental materials (foreign)
26 Jul 21
F-10/A
Registration of securities (Canada) (amended)
15 Nov 19
Proxies
No filings
Other
EFFECT
Notice of effectiveness
4 Jan 24
CORRESP
Correspondence with SEC
2 Jan 24
UPLOAD
Letter from SEC
27 Dec 23
EFFECT
Notice of effectiveness
22 Nov 19
CERT
Certification of approval for exchange listing
8 Oct 19
CT ORDER
Confidential treatment order
21 Apr 14
CT ORDER
Confidential treatment order
10 Feb 14
UPLOAD
Letter from SEC
10 Dec 12
CORRESP
Correspondence with SEC
5 Dec 12
CORRESP
Correspondence with SEC
4 Oct 12
Ownership
SC 13G
Nantahala Capital Management, LLC
14 Feb 24
SC 13G/A
HIRSCHMAN ORIN
7 Feb 24
SC 13G
HIRSCHMAN ORIN
29 Nov 23
SC 13D
Soleus Capital Master Fund, L.P.
28 Nov 23
SC 13D
Investissement Quebec
13 Nov 23
SC 13G/A
Soleus Capital Master Fund, L.P.
14 Feb 23
SC 13G/A
MORGAN STANLEY
10 Feb 23
SC 13G/A
Soleus Capital Master Fund, L.P.
14 Nov 22
SC 13G
MORGAN STANLEY
11 Feb 22
SC 13G/A
Soleus Capital Master Fund, L.P.
10 Feb 22